Evidence map›Paper›PMID 30971918›Full record

ArticleFrontiers in pharmacology2019

Polytropic Influence of

Jiecan Zhou, Fazhong He, Bao Sun, Rong Liu, Yongchao Gao, Huan Ren, Yan Shu, Xiaoping Chen, Zhaoqian Liu, Honghao Zhou and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Frontiers in genetics · 2022
    Article
  5. Annals of translational medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Jiecan ZhouDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Fazhong HeDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Bao SunDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Rong LiuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Yongchao GaoDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Huan RenDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Yan ShuDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, United States.
Xiaoping ChenDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Zhaoqian LiuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Honghao ZhouDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Sheng DengDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Heng XuDepartment of Laboratory Medicine, Precision Medicine Center, and Precision Medicine Key Laboratory of Sichuan Province, Collaborative Innovation Center, West China Hospital, Sichuan University, Chengdu, China.
Jianmin LiDepartment of Respiratory Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Linyong XuDepartment of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.
Wei ZhangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
PharmacoGenetics (China) · CNCentral South University · CNXiangya Hospital Central South University · CNHunan Normal University · CNSichuan University · CNUniversity of Maryland, Baltimore · USUniversity of South China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tribbles homolog 3 (

Indexed as

antihypertensive agentsessential hypertensionpolymorphismrs2295490TRIB3

Identifiers

PMID30971918
PMCPMC6445854
OpenAlexW2923736308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.